The observed loss of MLH1/PMS2 expression aligns with previous evidence showing that sporadic MLH1 promoter hypermethylation represents the most frequent cause of MMR deficiency in endometrial neoplasia. Here, MLH1 is linked to mismatch repair cancer syndrome 1.